Coca Cola Economics Health Economics Healthcare Equity Hepatitis C Public health Policy

What can Big Pharma learn from Coca Cola?

Growing up in Ghana I always knew Coca Cola was a Ghanaian Company and would have continued to believe that until Coca Cola refused to honor economic sanctions on the Apartheid South African government. The big Beverage Company continued business in South African amid protests in Africa and pressure from Black Activist in the US. […]

Advertisements
Clinical Trials cultural competency Disease Control Health Economics Healthcare Equity Hepatitis C immunization Immunization conspiracy theories implicit bias Public health Policy Racial Equity vaccine safety

How we can ensure that Advances in Medicine Benefits All

As a student in School of Public Health I learned one basic fact of life; new ideas in most fields including medicine usually benefit the most advantaged in society the most. This lesson will follow me when I started practicing medicine as a physician in Baltimore City. In the clinics and the wards in which […]

Barriers to healthcare Global Health Health Economics Healthcare Equity Hepatitis C International health Public health Policy

HEPATITIS C ELIMINATION; WHAT ARE THE BARRIERS?

In a prior post earlier in the year I wrote on this topic. A closer look at the current global situation suggests that whilst the cost of Hepatitis C (HCV) treatment may appear to be a major barrier there are many nations in the world that have managed to overcome that. In this piece I […]

Alternative medicine Cannabis Controlled substance laws cultural competency Disease Control featured government and politics Health Economics Health education Healthcare Equity Hepatitis C HIV Stigma Medical Marijuana National Public Health Emergency opioid crisis opioid epidemic police behavior Race and health racial discrimination racism in health Rural Health societal change Uncategorized War on drugs

The war on drugs; who won that war?

I first saw her in my clinic seeking care for HIV but when we first met like most patients with her medical condition she was not an ideal patient. The decision to start her on ART Antiretroviral therapy in those days when the only single tablet regimen was Atripla (Tenofovir/Emtrictabine/Efavirenz) was not an easy one […]